Shudo E - Search Results

1

Modeling complex decay profiles of hepatitis B virus during antiviral therapy.

Dahari H, Shudo E, Ribeiro RM, Perelson AS. Dahari H, et al. Among authors: shudo e. Hepatology. 2009 Jan;49(1):32-8. doi: 10.1002/hep.22586. Hepatology. 2009. PMID: 19065674 Free PMC article.

2

Modelling hepatitis C virus kinetics: the relationship between the infected cell loss rate and the final slope of viral decay.

Dahari H, Shudo E, Cotler SJ, Layden TJ, Perelson AS. Dahari H, et al. Among authors: shudo e. Antivir Ther. 2009;14(3):459-64. Antivir Ther. 2009. PMID: 19474480 Free PMC article.

3

Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128).

Guedj J, Dahari H, Shudo E, Smith P, Perelson AS. Guedj J, et al. Among authors: shudo e. Hepatology. 2012 Apr;55(4):1030-7. doi: 10.1002/hep.24788. Epub 2012 Feb 15. Hepatology. 2012. PMID: 22095398 Free PMC article. Clinical Trial.

4

Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon alpha-2b.

Shudo E, Ribeiro RM, Perelson AS. Shudo E, et al. J Viral Hepat. 2008 May;15(5):379-82. doi: 10.1111/j.1365-2893.2008.00977.x. Epub 2008 Feb 11. J Viral Hepat. 2008. PMID: 18266841 Free PMC article.

5

Modelling hepatitis C virus kinetics during treatment with pegylated interferon alpha-2b: errors in the estimation of viral kinetic parameters.

Shudo E, Ribeiro RM, Perelson AS. Shudo E, et al. J Viral Hepat. 2008 May;15(5):357-62. doi: 10.1111/j.1365-2893.2007.00954.x. J Viral Hepat. 2008. PMID: 18380660 Free PMC article.

6

Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.

Lau GK, Cooksley H, Ribeiro RM, Powers KA, Shudo E, Bowden S, Hui CK, Anderson J, Sorbel J, Mondou E, Rousseau F, Lewin S, Perelson AS, Locornini S, Naoumov NV. Lau GK, et al. Among authors: shudo e. Antivir Ther. 2007;12(5):705-18. Antivir Ther. 2007. PMID: 17713154 Clinical Trial.

7

Mathematical modeling of HCV infection and treatment.

Dahari H, Shudo E, Ribeiro RM, Perelson AS. Dahari H, et al. Among authors: shudo e. Methods Mol Biol. 2009;510:439-53. doi: 10.1007/978-1-59745-394-3_33. Methods Mol Biol. 2009. PMID: 19009281

8

A hepatitis C viral kinetic model that allows for time-varying drug effectiveness.

Shudo E, Ribeiro RM, Talal AH, Perelson AS. Shudo E, et al. Antivir Ther. 2008;13(7):919-26. Antivir Ther. 2008. PMID: 19043926

9

Modeling HCV kinetics under therapy using PK and PD information.

Shudo E, Ribeiro RM, Perelson AS. Shudo E, et al. Expert Opin Drug Metab Toxicol. 2009 Mar;5(3):321-32. doi: 10.1517/17425250902787616. Expert Opin Drug Metab Toxicol. 2009. PMID: 19331594 Free PMC article. Review.

10

CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.

Klatt NR, Shudo E, Ortiz AM, Engram JC, Paiardini M, Lawson B, Miller MD, Else J, Pandrea I, Estes JD, Apetrei C, Schmitz JE, Ribeiro RM, Perelson AS, Silvestri G. Klatt NR, et al. Among authors: shudo e. PLoS Pathog. 2010 Jan 29;6(1):e1000747. doi: 10.1371/journal.ppat.1000747. PLoS Pathog. 2010. PMID: 20126441 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters